Iles

Sainte Marguerite en Provence Wines Launch in the US: An Unconventional and Contemporary Take on Provence Rosé

Retrieved on: 
Wednesday, June 7, 2023
Fayard, FAMILY, Symphonie, Life Is Fruity, Fantastique, Light, Vermentino, Pernod Ricard Winemakers, Carbon, Certification, Grain, AOC, Crave, Iles, Soil, Herbicide, Love, Citrus, Pleasure, Knowledge, Lionel, House, Glass, Environment, Insecticide, Wine, Restaurant, Viticulture, Grenache

NEW YORK, June 7, 2023 /PRNewswire/ -- Pernod Ricard USA announces the launch of Sainte Marguerite en Provence rosé wines in the US market, offering free spirited rosé lovers an avant-garde approach to Provence rosé this summer. Sainte Marguerite en Provence joined Pernod Ricard's portfolio of premium wines and spirits in late 2022 and makes its debut in the US market ahead of National Rosé Day on June 10. Sainte Marguerite en Provence is characterized by a family history based on passion, high standards and a vision for the wines of Provence. Sainte Marguerite en Provence has two signature rosé wines – Symphonie and Fantastique – beloved for their finesse and elegance.

Key Points: 
  • NEW YORK, June 7, 2023 /PRNewswire/ -- Pernod Ricard USA announces the launch of Sainte Marguerite en Provence rosé wines in the US market, offering free spirited rosé lovers an avant-garde approach to Provence rosé this summer.
  • Sainte Marguerite en Provence is characterized by a family history based on passion, high standards and a vision for the wines of Provence.
  • Sainte Marguerite en Provence has two signature rosé wines – Symphonie and Fantastique – beloved for their finesse and elegance.
  • Starting this spring, Sainte Marguerite will offer free-spirited rosé drinkers a contemporary way to take pleasure in Provence rosé and the French Mediterranean lifestyle."

Fresenius Kabi Announces FDA Approval of SMOFlipid® Lipid Injectable Emulsion for Pediatric Patients Requiring Parenteral Nutrition

Retrieved on: 
Thursday, March 24, 2022
Medical Devices, Medical Supplies, FDA, Children, Fitness & Nutrition, Other Health, Health, Consumer, Pharmaceutical, Parenteral nutrition, Lipid, Human, Fresenius (company), Glucose, Oil, Neck, ASPEN, Electrolyte, Organic acid, Multimedia, MCT, Adult, Medical Affairs Bureau, Route of administration, Administration, Olive oil, Pediatrics, ILE, Light, ESPEN, Infusion therapy, Vitamin, Fats, Maximal and minimal elements, Gastrointestinal tract, Iles, FDA, Carbohydrate, Patient, Pharmaceutical industry, Dietary supplement, Dentistry

Fresenius Kabi announced today it has been granted an expanded indication for SMOFlipid Lipid Injectable Emulsion (ILE) for pediatric patients in the United States, including term and preterm neonates, making it the first and only four-oil lipid emulsion for parenteral nutrition patients of every age.1 SMOFlipid can be used throughout the continuum of care from the hospital to home care settings.

Key Points: 
  • Fresenius Kabi announced today it has been granted an expanded indication for SMOFlipid Lipid Injectable Emulsion (ILE) for pediatric patients in the United States, including term and preterm neonates, making it the first and only four-oil lipid emulsion for parenteral nutrition patients of every age.1 SMOFlipid can be used throughout the continuum of care from the hospital to home care settings.
  • View the full release here: https://www.businesswire.com/news/home/20220324005347/en/
    SMOFlipid Lipid Injectable Emulsion, now FDA approved for pediatric patients requiring parenteral nutrition.
  • (Graphic: Business Wire)
    The FDA approval of SMOFlipid for pediatric patients represents an important expansion of our parenteral nutrition portfolio and our continued commitment to providing innovative nutrition products to our clinical partners and the patients they serve, said Gordon Sacks, PharmD., senior director Medical Affairs, Fresenius Kabi USA.
  • Being able to meet these needs now with SMOFlipid for pediatric patients demonstrates our dedication to innovation when it comes to helping patients thrive on parenteral nutrition.

iVention Joins the Tetra Partner Network to Meet Customer Demand for Data-Engineered Scientific Workflows

Retrieved on: 
Wednesday, December 8, 2021
Cloud, Tetra, Laboratory information management system, LIMS, Business development, Heart, Informatics, Electronic lab notebook, View, Efficiency, ELN, Industry, CEO, Iles, Partnership, Machine learning, R, Science, SDMS, Laboratory, Multimedia, VP, Data science, TDP, Solution, AI, LES, Medical device, Fine chemical

We welcome the opportunity to collaborate with such a future-looking company to help customers achieve the data innovations they most need."

Key Points: 
  • We welcome the opportunity to collaborate with such a future-looking company to help customers achieve the data innovations they most need."
  • As a Tetra Partner, iVention can amplify scientific data value for customers through the Tetra Data Platform (TDP) - the industry's only R&D focused, vendor-agnostic, and cloud-native platform.
  • "By joining the Tetra Partner Network, iVention can continue to focus on developing valuable capabilities within our informatics products while also improving the efficiency of our customers' scientific applications and workflows."
  • Through open collaboration, the Tetra Partner Network functions as the only industry-wide catalyst to replatform scientific data to the cloud as a customer's first step in the journey to a digital lab.

Global Parenteral Nutrition Market Size, Share, Trends Analysis & Forecast Report 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, November 1, 2021
Food, Beverage, Health, Retail, Fitness & Nutrition, Pharmaceutical, Malnutrition, Nutrient, Parenteral nutrition, USD, Cancer, Iles, Patient, Route of administration, Short bowel syndrome, Adoption, FDA, Water supply, U.S. FDA, Life, PN, Adult, Intake, CAGR, Awareness, Diabetes, Conditional sentence, Accident, LATAM, Prevalence, Incidence, MEA, Jean-Louis Vincent, Dietary supplement

The "Global Parenteral Nutrition Market Size, Share & Trends Analysis Report by Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion), by Region (North America, Europe, APAC, LATAM, MEA), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Parenteral Nutrition Market Size, Share & Trends Analysis Report by Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion), by Region (North America, Europe, APAC, LATAM, MEA), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global parenteral nutrition market size is expected to reach USD 9.4 billion by 2028.
  • It is expected to expand at a CAGR of 5.9% from 2021 to 2028.
  • Parenteral nutrition (PN) plays a vital role in supporting better health outcomes as malnutrition can have a serious impact on hospitalized patients.

E2 Optics appoints Gary Iles as new Chief Revenue Officer

Retrieved on: 
Wednesday, December 2, 2020
Corporate finance, Cision, Vocus, Everything2, Iles

ENGLEWOOD, Colo., Dec. 2, 2020 /PRNewswire-PRWeb/ --E2 Optics, the leader in technology infrastructure solutions and one of the fastest-growing companies in the nation, is delighted to announce that Gary Iles has joined our executive team as our Chief Revenue Officer.

Key Points: 
  • ENGLEWOOD, Colo., Dec. 2, 2020 /PRNewswire-PRWeb/ --E2 Optics, the leader in technology infrastructure solutions and one of the fastest-growing companies in the nation, is delighted to announce that Gary Iles has joined our executive team as our Chief Revenue Officer.
  • Mr. Iles brings more than 15 years of C-suite experiences, evolving revenue engines for start-ups and enterprise companies.
  • An accomplished technology executive, Mr. Iles, is a data-driven, collaborative leader whose practical experiences run the gamut across the revenue stream, including Marketing, Partnerships, Product, and Sales.
  • "Name-brand companies are developing important and innovative customer experiences that happen over the integrated infrastructure solutions that E2 Optics deploys.

North American Palladium Acquires a 51% Interest in the Sunday Lake PGM Project`

Retrieved on: 
Monday, August 19, 2019
Chemical elements, Chemistry, Atoms, Abitibi-Témiscamingue, North American Palladium, Thunder Bay District, Palladium, Lac des Îles igneous complex, Iles, Palladium as an investment

We have demonstrated that the PGM Zone has significant lateral continuity and are now able to focus on areas of enhanced thickness and grade.

Key Points: 
  • We have demonstrated that the PGM Zone has significant lateral continuity and are now able to focus on areas of enhanced thickness and grade.
  • The Sunday Lake PGM Project is located 25 km north of Thunder Bay in Jacques Township, approximately 60 km south of NAPs Lac des Iles Mine operations (LDI).
  • About North American Palladium Ltd.
    North American Palladium (TSX:PDL) (OTC PINK:PALDF) is a Canadian company with 25 years of production at the Lac des Iles Mine in a low-risk jurisdiction northwest of Thunder Bay, Ontario.
  • North American Palladium is the worlds only pure play palladium producer.